ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 191 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $406,000 | -19.1% | 19,549 | -40.5% | 0.01% | -30.0% |
| Q2 2018 | $502,000 | -24.7% | 32,849 | +10.6% | 0.01% | -28.6% |
| Q1 2018 | $667,000 | -25.1% | 29,699 | +0.3% | 0.01% | -26.3% |
| Q4 2017 | $891,000 | -15.8% | 29,599 | +5.4% | 0.02% | -9.5% |
| Q3 2017 | $1,058,000 | +39.6% | 28,091 | +3.3% | 0.02% | +23.5% |
| Q2 2017 | $758,000 | -24.2% | 27,191 | -6.5% | 0.02% | -29.2% |
| Q1 2017 | $1,000,000 | +22.0% | 29,091 | +2.3% | 0.02% | +26.3% |
| Q4 2016 | $820,000 | +5025.0% | 28,450 | +5590.0% | 0.02% | – |
| Q2 2016 | $16,000 | +23.1% | 500 | 0.0% | 0.00% | – |
| Q1 2016 | $13,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |